131220 — Daihan Scientific Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual income statement for Daihan Scientific Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	61,508	66,281	72,280	73,702	71,694
Cost of Revenue
Gross Profit	15,458	18,449	21,564	22,170	19,853
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	58,528	60,416	65,055	67,535	67,469
Operating Profit	2,980	5,865	7,224	6,167	4,225
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,076	6,102	7,514	6,424	4,552
Provision for Income Taxes
Net Income After Taxes	2,752	5,015	6,242	5,222	3,926
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,709	3,767	4,702	3,845	2,693
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,709	3,767	4,702	3,845	2,693
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	312	528	661	542	384
Dividends per Share